Jiangsu Jibeier Pharmaceutical Co., Ltd.

Equities

688566

CNE100004041

Pharmaceuticals

End-of-day quote Shanghai S.E. 06:00:00 2024-05-30 pm EDT 5-day change 1st Jan Change
25.14 CNY +1.91% Intraday chart for Jiangsu Jibeier Pharmaceutical Co., Ltd. +0.60% -19.91%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Jibeier Pharmaceutical Gets Patents for Two Products MT
Jiangsu Jibeier Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Jibeier Pharmaceutical's Taxane Compound Method Gets Patent; Shares Down 3% MT
Jiangsu Jibeier Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Jiangsu Jibeier Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Jiangsu Jibeier Pharmaceutical Co., Ltd.(XSSC:688566) added to S&P Global BMI Index CI
Jiangsu Jibeier Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Jiangsu Jibeier Pharmaceutical Co., Ltd. announced that it expects to receive CNY 298.1619 million in funding CI
Certain A Shares of Jiangsu Jibeier Pharmaceutical Co., Ltd. are subject to a Lock-Up Agreement Ending on 18-MAY-2023. CI
Jiangsu Jibeier Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Jiangsu Jibeier Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Jiangsu Jibeier Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Jiangsu Jibeier Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
JiangsuJibeier Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
JiangsuJibeier Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
JiangsuJibeier Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021 CI
Yee Hop : Sells 30% Stake in Research Arm to Jiangsu Jibeier MT
Shenzhen Huahong Marine Biological Medicine Co., Ltd announced that it expects to receive CNY 90 million in funding from Shenzhen BGI Marine Sci & Tech Co.Ltd, JiangsuJibeier Pharmaceutical Co., Ltd. CI
Jiangsujibeier Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021 CI
JiangsuJibeier Pharmaceutical Co., Ltd.(SHSE:688566) added to Shanghai Stock Exchange Composite Index CI
JiangsuJibeier Pharmaceutical Co., Ltd.(SHSE:688566) added to Shanghai Stock Exchange A Share Index CI
Certain A Shares of JiangsuJibeier Pharmaceutical Co., Ltd. are subject to a Lock-Up Agreement Ending on 18-MAY-2021. CI
JiangsuJibeier Pharmaceutical Co., Ltd. Announces Earnings Results for the First Quarter Ended March 31, 2021 CI
Jiangsujibeier Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020 CI
Jiangsu Jibeier Pharmaceutical Co., Ltd. Reports Earnings Results for the First Three Quarters of 2020 CI
Chart Jiangsu Jibeier Pharmaceutical Co., Ltd.
More charts
Jiangsu Jibeier Pharmaceutical Co Ltd is a company engaged in the research, development, production and sales of drugs. The Company's products are comprised of tablets, capsules and eye drops. The tablet products include Leucogen tablets, Nitrendipine and Atenolol tablets, Aceclofenac Enteric-coated tablets and Asarone tablets. The Company's products are used to improve white blood cells, treat high blood pressure, eye infections and other diseases.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
25.14
Average target price
-
Consensus

Annual profits - Rate of surprise